Skip to content

R&D at other companies

Odysight.ai logo
Odysight.aiODYS
$2.56M+2.8%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$15.16M+42.5%
Safe Pro Group Inc. logo
Safe Pro Group Inc.SPAI
$360.4K
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$3.29M+14.5%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$345M+0.3%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$48.55M+11.2%

Other financials

Income statement

See full
Revenue$4.0M-40.5%
Gross profit$2.0M-36.0%
Operating income-$2.0M-120%
Net income-$3.4M-218%
EPS (diluted)-$0.11-200%

Balance sheet

See full
Cash & equivalents$11.7M-17.1%
Total debt$6.0M-36.6%
Total equity-$8.8M-442%
Total assets$17.7M-14.4%

Cash flow

See full
Operating cash flow-$3.7M-148%

Valuation

See full
Market cap$55.06M+3.9%
Enterprise value$49.43M-4.8%
P/S3.3×+1.3×

Profitability

See full
Gross margin46%+0.9pp
Operating margin-57.2%-104pp
Net margin-70%+176pp

Returns & leverage

See full
Return on equity-255.5%
Debt / equity0.7×+0.7×
Current ratio0.8×-0.7×

Where this comes from

Reported directly by Spectral AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Spectral AI, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Spectral AI, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Spectral AI, Inc.'s R&D?
Spectral AI, Inc. (MDAI) reported R&D of $2M in Q1 2026.
How has Spectral AI, Inc.'s R&D changed year-over-year?
Spectral AI, Inc.'s R&D decreased by 44.4% year-over-year, from $3.6M to $2M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.